The global airway management devices market size was estimated at USD 2.32 billion in 2023 and is projected to grow at a compound annual growth rate (CAGR) of 6.39% from 2024 to 2030. The increasing prevalence of respiratory diseases is predicted to be a high-impact rendering driver of this market. According to the study published by the National Library of Medicine in December 2023, global Chronic Obstructive Pulmonary Disease (COPD) prevalence was projected to approach 600 million patients worldwide by 2050, representing a relative increase of 23% in the number of people with COPD compared with 2020.
This high prevalence, coupled with the rise in anesthesia usage due to an upsurge in surgeries, is anticipated to boost the demand for advanced devices, thus positively impacting the market growth. The increasing demand for emergency treatment for prolonged diseases and protracted therapies associated with lung disorders in children and adults is anticipated to drive market growth.
In addition, the outbreak of the COVID-19 pandemic has also boosted the demand for respiratory devices. For instance, according to the study published by the National Library of Medicine in January 2022, for airway managementof COVID-19 patients, most physicians preferred using a video-laryngoscope with a remote monitor and disposable Macintosh blade. In addition, several devices like C-MAC, Glidescope, McGrath, Airtraq, and King Vision were used during the COVID-19 pandemic. Thus, the increased demand for respiratory equipment & tools during the pandemic may have supported the industry's growth.
Patients suffering from contagious diseases and cardiac ailments often experience airway complications, which require instantaneous treatment. Similarly, road accident victims also require immediate airway clearance for their safety. Due to the growth in the prevalence of such cases, the demand for airway management devices has witnessed an uptrend. The increase in emergency and intensive care unit patient admissions is driving the market globally.
Market growth stage is high, and the pace of the market growth is accelerating. The market is characterized by a moderate degree of innovation due to rapid technological advancements and rising developments of innovative respiratory equipment. Companies are entering the market and bringing novel instruments and devices, which are expected to drive innovation in the industry. Furthermore, adopting novel technologies like artificial Intelligence (AI) in airway management is also expected to spur market innovation. As per the article published by the Springer Nature Group in July 2023, robotic intubation improves precision. Furthermore, novel instruments are available in the industry. According to the article published by the MDPI in September 2023, two new devices, video laryngeal masks, and articulated styles, are available in the market.
The market is also characterized by the leading players, moderate level of merger and acquisition (M&A) activity. This is due to several factors, including the desire to gain a competitive advantage in the industry and the need to consolidate in a rapidly growing market. Major industry participants are acquiring firms providing products for airway management. For instance, in June 2023, SunMed, a major medical device manufacturer, entered into a definitive agreement with Avanos Medical, Inc. to purchase Avanos respiratory health business, including the MICROCUFF and BALLARD product lines. The company offers airway management products like endotracheal tube adapters with ports under these brands. Such acquisitions are expected to propel industry growth in the forecast period.
Furthermore, the industry participants operating in the industry are focusing on increasing their presence in regions and improving access to the instruments and devices required during surgeries and respiratory therapies. For instance, in October 2023, ABM Respiratory Care, an innovative respiratory care solutions provider, announced the U.S. exclusive distribution partnership with Mercury Medical for non-government acute care facilities. This partnership brought ABM Respiratory Care’s BiWaze Clear and BiWaze Cough products to hospitals nationwide. It includes products that can help in airway clearance. Thus, such distribution agreements from the major players are expected to improve access to these products in various countries and regions.
In terms of product, the supraglottic devices segment led the market with the largest market revenue share of 35.02% in 2023. The growing demand for these products can be attributed to their associated benefits. The most important advantage includes easy tracheal placement, which leads to improved patient safety. In addition, supraglottic products, such as indirect video laryngoscopes, are widely used in many clinical applications and prevent the need for tracheal intubation. Furthermore, major companies operating in the industry are offering supraglottic devices. For instance, Teleflex Incorporated, a major industry participants provide supraglottic products like LMA Unique EVO Airway and LMA Supreme Airway. Thus, the availability of products from key companies is expected to drive the preference of patients and anesthesiologists toward these devices.
The laryngoscopes segment is anticipated to witness the fastest CAGR over the forecast period. Industry players are innovating laryngoscopes and bringing novel devices into this segment. For instance, in January 2023, Timesco Healthcare introduced a new video laryngoscope to help intubate patients with difficult airways at Arab Health 2023. Thus, such innovations and increasing product launches are expected to drive segment growth during the forecast period.
Based on the application, the anesthesia segment led the market with a largest revenue share of 53.49% in 2023, owing to anesthesiologists high preference and adoption of these devices in surgical operative procedures. The increasing adoption is presumed to be a result of high efficiency in airway clearance and maintenance of proper ventilation without compromising patient safety during operative procedures.
The emergency medicine segment is projected to witness the fastest CAGR over the forecast period. The emergency clinicians generally encounter difficult airways. Many devices have been designed to help manage the difficult airway. They comprise a variety of video, fiber optic, optical, and mechanical technologies to allow the operator to obtain a better view of the larynx. These instruments are useful for managing difficult or failed airways and routine intubation. Thus, due to the wide utility of airway management devices in emergency medicine, the segment is expected to boost significantly over the forecast period.
Based on the end use, the hospital segment led the market in 2023 with the largest market share of 59.09, due to the high patient turnaround, frequent readmissions, and large procedure volumes. In addition, supportive infrastructure enables successful operative practices involving airway management, thus leading to a higher share. Moreover, the hospitals are undertaking initiatives and studies to reduce adverse events related to airway management. For instance, in August 2023, the Royal Hospital for Children (RHC) in Glasgow conducted a study, and it concluded that the Paediatric Structured CRitical Airway Management (SCRAM) Bag should be implemented across the hospital. The increasing adoption of novel devices across hospitals is expected to propel the segment growth.
The home care segment is projected to witness the fastest CAGR over the forecast period due to the increasing launches of instruments and equipment for managing airways in home settings. For instance, in May 2023, Air Liquide Medical Systems introduced the ALNEST N1 Silent mask that can be used at home by multiple adult patients who have been prescribed a Bilevel positive airway pressure therapy (BiPAP) or continuous positive airway pressure therapy (CPAP).
North America dominated the market with a revenue share of 39.10% in 2023. This dominance can be attributed to the fact that many companies manufacturing and distributing respiratory products are located in the U.S. and perform most of their business in this region. Moreover, new companies are entering the industry, which is expected to drive regional market growth during the forecast period. For instance, Epic Airway Systems, Inc., a U.S.-based company founded in 2021, is developing an airway device that can be useful in the operating room and prehospital settings. The company has developed eight rounds of prototypes for the device. Thus, such developments by emerging players are expected to propel regional growth.
Asia Pacific is anticipated to witness the fastest CAGR during the forecast period, due to the increase in the outsourcing of the manufacturing of these devices to Asia Pacific countries, such as India and China. Furthermore, high R&D investment by the global players and the presence of unexplored opportunities in this region serve as high growth rendering drivers.
Some of the key players operating in the market include Medtronic, Teleflex Incorporated, Ambu A/S, Medline Industries, LP, and BD among others. These companies adopt various strategies to maintain and increase their market share. Strategies such as new product development, partnership, collaboration and agreement, and acquisitions are widely adopted by the key players.
Conus Airway, Mercury Medical, and Armstrong Medical Ltd are some of the emerging market participants in the global market. These players adopt various strategies to increase their market share and expand their geographic presence. Customer acquisition strategies, partnerships, and expansion of product portfolio are some of the strategies adopted by these players.
In September 2023, Verathon, a major company offering airway management solutions, launched a handheld video laryngoscope, the GlideScope Go 2. The device is designed for maximum durability and allows storage for up to 40 hours of video.
In June 2023, Teleflex Incorporated., a major industry player and the Shenzhen Insighters Medical Technology Co., Ltd entered into a partnership to distribute the Insighters Video Laryngoscope system in the U.S. This system was developed to examine the glottic airway and enable endotracheal intubation.
In July 2023, Inogen, Inc., a medical technology organization, entered into a definitive agreement to acquire a France headquartered private company, Physio-Assist SAS. Physio-Assist manufactures and develops Simeox, a technology-enabled airway clearance device.
Market size value in 2024
USD 2.48 billion
Revenue forecast in 2030
USD 3.59 billion
CAGR of 6.39% from 2024 to 2030
Base year for estimation
2018 - 2022
2024 - 2030
Revenue in USD million/billion and CAGR from 2024 to 2030
Revenue forecast, company ranking, competitive landscape, growth factors, and trends
Product, application, end-use, region
North America; Europe; Asia Pacific; Latin America; MEA
U.S.; Canada; Germany; U.K.; France; Italy; Spain; Denmark; Sweden; Norway; China; Japan; India; South Korea; Australia; Brazil; Mexico; Argentina; South Africa; Saudi Arabia; UAE; and Kuwait
Key companies profiled
Medtronic; Teleflex Incorporated; Ambu A/S; Intersurgical Ltd; BD; Medline Industries; LP; Armstrong Medical Ltd; ICU Medical (Smiths Medical, Inc.); Mercury Medical; Convatec Inc.
Free report customization (equivalent up to 8 analyst’s working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options
Avail customized purchase options to meet your exact research needs. Explore purchase options
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this report, Grand View Research has segmented the global airway management devices market report based on product, application, end-use, and region:
Product Outlook (Revenue, USD Million, 2018 - 2030)
Laryngeal Airway Masks
Application Outlook (Revenue, USD Million, 2018 - 2030)
End-use Outlook (Revenue, USD Million, 2018 - 2030)
Regional Outlook (Revenue, USD Million, 2018 - 2030)
b. The global airway management devices market size was estimated at USD 2.32 billion in 2023 and is expected to reach USD 2.48 billion in 2024.
b. The global airway management devices market is expected to grow at a compound annual growth rate of 6.39% from 2024 to 2030 to reach USD 3.59 billion by 2030.
b. North America dominated the airway management devices market with a share of 39.10% in 2023. This is attributable to the supportive government initiatives, substantial implementation of practice guidelines and the high prevalence of major respiratory diseases.
b. Some key players operating in the airway management devices market include Medtronic, Teleflex Incorporated, Ambu A/S, ICU Medical (Smiths Medical, Inc.), Medline Industries, LP.
b. Key factors that are driving the airway management devices market growth include increasing prevalence of respiratory diseases, need of emergency treatment for prolonged illnesses, protracted treatments associated with lung diseases, and advent of advanced techniques.
NEED A CUSTOM REPORT?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities. Contact us now
"The quality of research they have done for us has been excellent."